大肿瘤抑制因子和甲状腺自身抗体。
LATS and thyroid autoantibodies.
作者信息
Beall G N, Solomon D H
出版信息
Clin Exp Immunol. 1968 Sep;3(7):615-9.
Abstract
A group of fifty-nine sera from fifty-three patients were bioassayed for LATS and assayed for autoantibodies to human thyroid. Seventy-five per cent had cytoplasmic autoantibodies and 44% contained LATS but the concurrence of these findings did not exceed chance. In a detailed analysis of forty-five of these sera, neither the titre of thyroglobulin antibody nor of cytoplasmic antibody correlated significantly with the LATS response index.
摘要
对来自53名患者的59份血清进行了长效甲状腺刺激素（LATS）生物测定，并检测了针对人甲状腺的自身抗体。75%的血清含有细胞质自身抗体，44%含有LATS，但这些结果的同时出现并未超过偶然概率。在对其中45份血清的详细分析中，甲状腺球蛋白抗体滴度和细胞质抗体滴度均与LATS反应指数无显著相关性。
相似文献
1
LATS and thyroid autoantibodies.大肿瘤抑制因子和甲状腺自身抗体。
Clin Exp Immunol. 1968 Sep;3(7):615-9.
2
[Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].[长效甲状腺刺激素（LATS）在甲状腺疾病中的作用及其与甲状腺抗体的关系]
Schweiz Med Wochenschr. 1967 Jul 15;97(28):898-904.
3
The long-acting thyroid stimulator.长效甲状腺刺激素
Sci Basis Med Annu Rev. 1970:21-30.
4
Can LATS be detected by immunofluorescence?是否可以通过免疫荧光检测到LATS？
J Clin Endocrinol Metab. 1969 Aug;29(8):1114-6. doi: 10.1210/jcem-29-8-1114.
5
What is the antibody specificity of LATS?LATS的抗体特异性是什么？
J Clin Endocrinol Metab. 1970 Oct;31(4):445-7. doi: 10.1210/jcem-31-4-445.
6
[Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].[碘对促甲状腺素、长效甲状腺刺激素、致突眼因子、甲状腺抗体及血清蛋白组分的甲状腺刺激和致突眼作用的灭活]
Klin Wochenschr. 1969 Aug 15;47(16):879-83. doi: 10.1007/BF01879921.
7
Changes in LATS and other thyoid autoantibody levels with therapy.治疗过程中LATS及其他甲状腺自身抗体水平的变化。
N Z Med J. 1974 Dec 11;80(529):495-6.
8
Failure to detect long-acting thyroid stimulator with the immunofluorescence technique.用免疫荧光技术未能检测到长效甲状腺刺激素。
Clin Exp Immunol. 1970 Jan;6(1):167-8.
9
[Determination of anti-thyroid antibody].[抗甲状腺抗体的测定]
Nihon Rinsho. 1979 Jun 29;Suppl:1511-4.
10
[Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].[具有长效促甲状腺作用的“LATS”免疫球蛋白的性质及其抗原定位]
Ann Inst Pasteur (Paris). 1970 Apr;118(4):539-46.
引用本文的文献
1
Treatment of thyrotoxicosis.甲状腺毒症的治疗。
Calif Med. 1970 Aug;113(2):55-65.
本文引用的文献
1
A stable sheep cell preparation for detecing thyroglobulin auto-antibodies and its clinical applications.一种用于检测甲状腺球蛋白自身抗体的稳定绵羊细胞制剂及其临床应用。
J Clin Pathol. 1961 Nov;14(6):654-60. doi: 10.1136/jcp.14.6.654.
2
3
Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.格雷夫斯病中长效甲状腺刺激素与循环甲状腺抗体之间的关系。
J Clin Endocrinol Metab. 1967 Dec;27(12):1758-60. doi: 10.1210/jcem-27-12-1758.
4
Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.甲状腺微粒成分对长效甲状腺刺激素的抑制作用。
J Clin Invest. 1966 Apr;45(4):552-61. doi: 10.1172/JCI105369.
5
On the immunological nature of the long acting thyroid stimulator.长效甲状腺刺激素的免疫学本质
J Clin Endocrinol Metab. 1966 Dec;26(12):1382-8. doi: 10.1210/jcem-26-12-1382.
Zotero 插件